Please login to the form below

Not currently logged in
Email:
Password:

asthma treatment

This page shows the latest asthma treatment news and features for those working in and with pharma, biotech and healthcare.

FDA grants priority review for AZ, Amgen’s tezepelumab for asthma

FDA grants priority review for AZ, Amgen’s tezepelumab for asthma

Drug 'has the potential to transform treatment for a broad population of severe asthma patients'. ... The companies’ FDA submission for tezepelumab for the treatment of severe asthma patients is based on results from the PATHFINDER clinical programme.

Latest news

More from news
Approximately 0 fully matching, plus 139 partially matching documents found.

Latest Intelligence

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    Such monitoring could also allow for early prediction of treatment success, eg in a study to evaluate asthma treatment outcomes. ... For example, monitoring heart rate and rhythm data in patients receiving post-treatment for myocardial infarction (MI) to

  • Allergies and asthma Allergies and asthma

    AIT with birch or grass pollen had a long-lasting preventive effect on asthma, up to seven years after the treatment was stopped. ... This evidence-based data demonstrates the need to manage allergies and asthma prenatally, as early treatment already

  • Pharma deals in July 2015 Pharma deals in July 2015

    Firstly the divestment for up to $300m to Genzyme of Caprelsa (vandetanib), an orphan drug treatment for thyroid carcinoma. ... In Japan, AZ paid $45m for an option with Kyowa Hakko Kirin to commercialise benralizumab (currently in phase III for

  • Pharma deals during July 2014 Pharma deals during July 2014

    Underscoring its strategy in focusing the business in the core areas, in July Baxter also announced the acquisition of AesRx, a private US company developing a phase II stage prophylactic treatment ... The acquisition of Almirall's respiratory business

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    Treatments successfully brought to market in this way include asthma treatment Flutiform, created by Skye Pharma, and restless legs syndrome treatment Targin.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Time for a new language for asthma?

    Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines. ... A comprehensive market research study has

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...